Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

Burn, J.; Gerdes, A.M.; Macrae, F.; Mecklin, J.P.; Moeslein, G.; Olschwang, S.; ... ; CAPP2 Investigators (2011)

Article / Letter to editor

• All authors: Burn, J.; Gerdes, A.M.; Macrae, F.; Mecklin, J.P.; Moeslein, G.; Olschwang, S.; Eccles, D.; Evans, D.G.; Maher, E.R.; Bertario, L.; Bisgaard, M.L.; Dunlop, M.G.; Ho, J.W.C.; Hodgson, S.V.; Lindblom, A.; Lubinski, J.; Morrison, P.J.; Murday, V.; Ramesar, R.; Side, L.; Scott, R.J.; Thomas, H.J.W.; Vasen, H.F.; Barker, G.; Crawford, G.; Elliott, F.; Movahedi, M.; Pylvanainen, K.; Wijnen, J.T.; Fodde, R.; Lynch, H.T.; Mathers, J.C.; Bishop, D.T.; CAPP2 Investigators
• Date: 2011-12-17
• Journal: Lancet
• Volume: 378
• Issue: 9809
• Pages: 2081 - 2087
• DOI: doi:10.1016/S0140-6736(11)61049-0